[go: up one dir, main page]

NO20043383L - Faste krystallinske stoffer av karvedilol og fremgangsmater for fremstilling av disse - Google Patents

Faste krystallinske stoffer av karvedilol og fremgangsmater for fremstilling av disse

Info

Publication number
NO20043383L
NO20043383L NO20043383A NO20043383A NO20043383L NO 20043383 L NO20043383 L NO 20043383L NO 20043383 A NO20043383 A NO 20043383A NO 20043383 A NO20043383 A NO 20043383A NO 20043383 L NO20043383 L NO 20043383L
Authority
NO
Norway
Prior art keywords
carvedilol
processes
preparation
solid crystalline
crystalline substances
Prior art date
Application number
NO20043383A
Other languages
English (en)
Norwegian (no)
Inventor
Shlomit Wizel
Ilan Kor
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23371828&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20043383(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20043383L publication Critical patent/NO20043383L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20043383A 2002-01-15 2004-08-13 Faste krystallinske stoffer av karvedilol og fremgangsmater for fremstilling av disse NO20043383L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34931002P 2002-01-15 2002-01-15
PCT/US2003/001137 WO2003059807A2 (fr) 2002-01-15 2003-01-15 Corps solides cristallins de carvedilol, et leurs procedes d'elaboration

Publications (1)

Publication Number Publication Date
NO20043383L true NO20043383L (no) 2004-08-13

Family

ID=23371828

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043383A NO20043383L (no) 2002-01-15 2004-08-13 Faste krystallinske stoffer av karvedilol og fremgangsmater for fremstilling av disse

Country Status (14)

Country Link
US (3) US6710184B2 (fr)
EP (1) EP1474133A4 (fr)
JP (1) JP2005515226A (fr)
KR (1) KR20040077872A (fr)
CN (1) CN1298322C (fr)
AU (1) AU2003205146A1 (fr)
CA (1) CA2472377A1 (fr)
HR (1) HRP20040673A2 (fr)
IS (1) IS7351A (fr)
MX (1) MXPA04006909A (fr)
NO (1) NO20043383L (fr)
PL (1) PL371409A1 (fr)
WO (1) WO2003059807A2 (fr)
ZA (1) ZA200405443B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6389455B1 (en) * 1998-09-22 2002-05-14 Richard C. Fuisz Method and apparatus for bouncing electronic messages
US20010036959A1 (en) * 2000-04-03 2001-11-01 Gabel Rolf Dieter Carvedilol-hydrophilic solutions
KR20030017569A (ko) 2000-06-28 2003-03-03 테바 파마슈티컬 인더스트리즈 리미티드 카르베딜올
US7122376B2 (en) * 2001-11-01 2006-10-17 Facet Analytical Services And Technology, Llc Calibration standards, methods, and kits for water determination
US7049146B2 (en) 2000-11-14 2006-05-23 Facet Analytical Services And Technology, Llc Calibration standards, methods, and kits for water determination
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
MXPA04006909A (es) 2002-01-15 2005-04-19 Teva Pharma Solidos cristalinos de carvedilol y procesos para su preparacion.
WO2003092622A2 (fr) * 2002-04-30 2003-11-13 Sb Pharmco Puerto Rico Inc. Monocitrate monohydrate de carvedilol
CA2492060C (fr) * 2002-06-27 2011-11-01 Sb Pharmco Puerto Rico Inc. Sels de phospate de carvedilol et/ou solvates de celui-ci, compositions et/ou methodes de traitement associees
AU2003251627A1 (en) * 2002-06-27 2004-01-19 Sb Pharmco Puerto Rico Inc. Carvedilol hydrobromide
US20040152756A1 (en) * 2002-07-15 2004-08-05 Wei Chen Carvedilol polymorph
WO2004094378A1 (fr) * 2003-04-21 2004-11-04 Matrix Laboratories Ltd Procede de fabrication de carvedilol, forme-ii
US20050037040A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of urea and ammonium lactate
US20050042182A1 (en) * 2003-08-13 2005-02-24 Moshe Arkin Topical compositions of urea
US20050036953A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of ammonium lactate
US20050042268A1 (en) * 2003-07-16 2005-02-24 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
SI21616A (sl) * 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
US20050069499A1 (en) * 2003-09-25 2005-03-31 Moshe Arkin Foamable compositions, processes of preparing same and uses thereof
JP2007512372A (ja) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール塩、対応する組成物、送達および／または治療方法
US20050169994A1 (en) * 2003-11-25 2005-08-04 Burke Matthew D. Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
US20060057075A1 (en) * 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
US20070043099A1 (en) * 2005-06-09 2007-02-22 Igor Lifshitz Crystalline forms of carvedilol and processes for their preparation
WO2007043938A1 (fr) * 2005-10-07 2007-04-19 Astrazeneca Ab Nouvelle forme cristalline de 3,5-dibromo-n-[(2s)-2-(4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl]-n-methylbenzamide, modification b
WO2007077111A1 (fr) * 2005-12-30 2007-07-12 F. Hoffmann-La Roche Ag Composés et méthodes pour la synthèse de carbazole
WO2008002683A2 (fr) 2006-06-28 2008-01-03 Teva Pharmaceutical Industries Ltd. Carvédilol phosphate
RU2366653C2 (ru) * 2006-07-03 2009-09-10 Ооо "Нанокриохимия" Способ получения рентгеноаморфной модификации карведилола
GB2442238B (en) * 2006-09-29 2008-10-01 Rolls Royce Plc Sheet metal blank
US20080249317A1 (en) * 2007-04-04 2008-10-09 Apotex Inc. Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
EP2257177A4 (fr) * 2007-11-14 2012-07-11 Manuel Gidekel Nouveaux extraits de deschampsia antarctica desv. dotés d'une activité antinéoplasique
US12091408B2 (en) * 2013-08-30 2024-09-17 Uti Limited Partnership Store overload-induced calcium release inhibitors and methods for producing and using the same
AU2014348523B2 (en) 2013-11-15 2019-01-03 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3319027A1 (de) 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten
FR2725623A1 (fr) 1994-10-18 1996-04-19 Flamel Tech Sa Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
US5760069A (en) 1995-02-08 1998-06-02 Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 Method of treatment for decreasing mortality resulting from congestive heart failure
US6730326B2 (en) 1997-07-22 2004-05-04 Roche Diagnostics Gmbh Thermodynamically stable modification of 1-(4-carbazolyl-oxy-3[2-(2-methoxyphenoxy)-ethylamino]-2-propanol process for its preparation and pharmaceutical compositions containing it
EP0893440A1 (fr) 1997-07-22 1999-01-27 Roche Diagnostics GmbH Une modification thermodynamique stabilisée de 1-(4-carbazolyloxy)-3[2-(2-methoxyphenoxy)ethylamino]- 2-propanole, un procédé pour sa préparation et une composition pharmaceutique qui la contient
HU227441B1 (en) * 1997-11-24 2011-06-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing carvedilol, enantiomers and salts thereof
DE19954569A1 (de) 1999-11-12 2001-05-17 Schwabe Willmar Gmbh & Co Pharmakologisch aktive Tetrahydrothiopyran-4-ol-Derivate, Verfahren zu ihrer Herstellung und Verwendung
KR20030017569A (ko) * 2000-06-28 2003-03-03 테바 파마슈티컬 인더스트리즈 리미티드 카르베딜올
JO2433B1 (en) 2001-01-25 2008-04-17 اف . هوفمان لاروش ايه جي Preparation of heterocyclic lindane landscapes
WO2003005970A2 (fr) * 2001-07-13 2003-01-23 Smithkline Beecham Corporation Polymorphe de carvedilol
KR100752549B1 (ko) 2001-09-28 2007-08-30 에프. 호프만-라 로슈 아게 카르베딜올의 유사다형태
MXPA04006909A (es) 2002-01-15 2005-04-19 Teva Pharma Solidos cristalinos de carvedilol y procesos para su preparacion.
CA2492060C (fr) 2002-06-27 2011-11-01 Sb Pharmco Puerto Rico Inc. Sels de phospate de carvedilol et/ou solvates de celui-ci, compositions et/ou methodes de traitement associees
US20040152756A1 (en) * 2002-07-15 2004-08-05 Wei Chen Carvedilol polymorph
SK285547B6 (sk) 2002-11-08 2007-03-01 Zentiva, A. S. Spôsob prípravy Carvedilolu
WO2004094378A1 (fr) 2003-04-21 2004-11-04 Matrix Laboratories Ltd Procede de fabrication de carvedilol, forme-ii
US7482471B2 (en) 2003-06-20 2009-01-27 Sun Pharmaceutical Industries Limited Process for preparation of 1-[9H-carbazol-4-yloxy]-3-[{2-(2-(-methoxy)phenoxy)-ethyl}-amino]-propan-2-ol
SI21616A (sl) 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
JP2007512372A (ja) 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール塩、対応する組成物、送達および／または治療方法
EP1723107A2 (fr) 2004-02-23 2006-11-22 Cadila Healthcare Ltd. Procede de preparation de carvedilol racemique
WO2005115981A2 (fr) 2004-04-22 2005-12-08 Usv Limited Nouveau procede de preparation de 1-(9h-carbazol-4-yloxy)-3-[[2-(-methoxyphenoxy)-ethyl] amino]-propan-2-ol
GB0411273D0 (en) 2004-05-20 2004-06-23 Cipla Ltd Process and product
US20090005429A1 (en) 2004-12-09 2009-01-01 Zach System S.P.A. Process for the preparation of carvedilol and its enantiomers
US20070027202A1 (en) 2005-06-07 2007-02-01 Ashok Kumar Process for the preparation of carvedilol and its salts
WO2007057316A2 (fr) 2005-11-16 2007-05-24 F. Hoffmann-La Roche Ag Nouveau procede de preparation de thoc
WO2007077111A1 (fr) 2005-12-30 2007-07-12 F. Hoffmann-La Roche Ag Composés et méthodes pour la synthèse de carbazole
KR100746455B1 (ko) 2006-02-23 2007-08-03 안국약품 주식회사 고광학순도의 키랄 카베딜롤의 제조방법

Also Published As

Publication number Publication date
PL371409A1 (en) 2005-06-13
WO2003059807A3 (fr) 2003-12-04
ZA200405443B (en) 2005-07-08
US7514467B2 (en) 2009-04-07
US7598396B2 (en) 2009-10-06
KR20040077872A (ko) 2004-09-07
IS7351A (is) 2004-07-13
CN1298322C (zh) 2007-02-07
HRP20040673A2 (en) 2005-06-30
US20040171665A1 (en) 2004-09-02
US20030166702A1 (en) 2003-09-04
WO2003059807A2 (fr) 2003-07-24
CA2472377A1 (fr) 2003-07-24
AU2003205146A1 (en) 2003-07-30
JP2005515226A (ja) 2005-05-26
US6710184B2 (en) 2004-03-23
CN1615133A (zh) 2005-05-11
EP1474133A2 (fr) 2004-11-10
MXPA04006909A (es) 2005-04-19
US20090163721A1 (en) 2009-06-25
EP1474133A4 (fr) 2006-02-01

Similar Documents

Publication Publication Date Title
NO20043383L (no) Faste krystallinske stoffer av karvedilol og fremgangsmater for fremstilling av disse
AU2003213606A8 (en) Mp53s as modifiers of the p53 pathway and methods of use
PH12012501372A1 (en) Proteasome inhibitors and methods of using the same
IL189021A0 (en) Solid dosage forms of valsartan and amlodipine and method of making the same
ZA200608180B (en) Solid product dissolver and method of use thereof
AU2003303398A1 (en) Dowhole chemical sensor and method of using same
NO20051503D0 (no) Pyrazolopyridiner og fremgangsmater for fremstilling og anvendelse av de samme.
NO20055026D0 (no) Indolonacetamid-derivater, fremgangsmate for fremstilling og anvendelse av disse
AU2003270769A8 (en) Functionalized materials and methods of using same
DK1589973T4 (da) Formulering og fremgangsmåder til behandling af thrombocytæmi
NO20054535D0 (no) Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme
NO20043295L (no) Faste salt-benzazepinforbindelser og deres anvendelse ved fremstilling av farmasoytiske forbindelser
NO20052859D0 (no) Fremgangsmate for fremstilling av resperidon og intermediater derav
AU2003297612A8 (en) 2-substituted-3-propenamide derivatives and methods of using the same
AU2003294684A8 (en) Ketoprofen compositions and methods of making them
AU2003284942A1 (en) Oral extended release tablets and methods of making and using the same
IS2679B (is) Örhylki með tafða og stýrða losun á perindópríli
ZA200704791B (en) Tablets for the sustained release of indapamide and preparation method thereof
NO20026192D0 (no) Metode og innretning for å detektere opphopning av faste stoffer
AU2003295881A8 (en) Lamps as modifiers of the p53 pathway and methods of use
AU2003228597A8 (en) Antibodies for enzymes of the omega-oxidation pathway and methods relating thereto
AU2003303094A8 (en) Mat2as as modifiers of the p53 pathway and methods of use
NO20034422D0 (no) Löfteverktöy IIb og fremgangsmåte for anvendelse av samme
AU2003278811A8 (en) Ldlrs as modifiers of the p53 pathway and methods of use
AU2003288698A8 (en) Methods of screening for anti-inflammatory drugs and use thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application